- Home
- BODI vs VTVT Comparison
BODI vs VTVT Comparison
Compare BODI & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- VTVT
- Stock Information
- Founded
- BODI 1998
- VTVT 2015
- Country
- BODI United States
- VTVT United States
- Employees
- BODI N/A
- VTVT N/A
- Industry
- BODI Industrial Machinery/Components
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- VTVT Health Care
- Exchange
- BODI Nasdaq
- VTVT Nasdaq
- Market Cap
- BODI 46.9M
- VTVT 47.9M
- IPO Year
- BODI N/A
- VTVT 2015
- Fundamental
- Price
- BODI $5.81
- VTVT $22.80
- Analyst Decision
- BODI Buy
- VTVT Strong Buy
- Analyst Count
- BODI 2
- VTVT 2
- Target Price
- BODI $10.00
- VTVT $35.50
- AVG Volume (30 Days)
- BODI 12.4K
- VTVT 5.7K
- Earning Date
- BODI 11-11-2025
- VTVT 11-11-2025
- Dividend Yield
- BODI N/A
- VTVT N/A
- EPS Growth
- BODI N/A
- VTVT N/A
- EPS
- BODI N/A
- VTVT N/A
- Revenue
- BODI $324,871,000.00
- VTVT $17,000.00
- Revenue This Year
- BODI N/A
- VTVT N/A
- Revenue Next Year
- BODI N/A
- VTVT N/A
- P/E Ratio
- BODI N/A
- VTVT N/A
- Revenue Growth
- BODI N/A
- VTVT N/A
- 52 Week Low
- BODI $3.38
- VTVT $12.62
- 52 Week High
- BODI $8.71
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- BODI 47.38
- VTVT 59.37
- Support Level
- BODI $5.34
- VTVT $22.42
- Resistance Level
- BODI $5.94
- VTVT $24.46
- Average True Range (ATR)
- BODI 0.42
- VTVT 1.32
- MACD
- BODI -0.10
- VTVT -0.23
- Stochastic Oscillator
- BODI 26.22
- VTVT 54.87
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.